Then, in September, the Trump Administration launched a crackdown on deceptive direct-to-consumer drug advertising, resulting in the FDA publishing over 55 warning letters to online sellers of compounded versions of GLP-1 medications that called for the removal of false and misleading promotional statements, claims of clinically proven weight-loss treatments, and using the words FDA-approved in advertising copy
Those with milder obesity, already active lifestyles, or genetic variants limiting GLP1R function may see slower progression
SCFAs stimulate L-cells to release GLP-1, while Akkermansia and mucosal-supportive microbes enhance enteroendocrine hormone sensitivity
Here are five of our Registered Dietitians favorite evidence-based strategies to boost your bodys own GLP-1 and support your long-term health goals
The comparison numbers tell an interesting story, but they should not be the only factor in choosing a medication